$344.00
A focused lab panel designed to evaluate reproductive hormones and ovarian reserve markers that influence fertility, cycle regularity, and reproductive planning.
Prescription treatments include a short medical intake at checkout. A licensed clinician reviews every order before anything is prescribed or shipped — if it is not approved, you are fully refunded.
Reproductive hormones: Estradiol, progesterone, total testosterone, free testosterone, and DHEA-S
Pituitary signaling: FSH and LH to assess ovarian communication and cycle regulation
Hormone availability: SHBG to understand biologically active hormone levels
Ovarian reserve markers: Anti Müllerian hormone (AMH)
Prolactin: Evaluated for its role in ovulation and cycle disruption
Thyroid function: TSH, free T4, and free T3 to assess metabolic and reproductive support
Nutrient and metabolic support: Vitamin D and ferritin
Cycle timing matters more for this panel than most. Proper timing helps ensure results are interpreted accurately in context.
For fertility-focused testing: schedule your draw during the mid-luteal phase, typically days 19 to 23 of a standard 28-day cycle.
For hormonal transition or perimenopause assessment: schedule your draw during the early follicular phase, typically days 1 to 5 of your cycle.
Cycle timing is not always predictable. You may reschedule your lab appointment if needed, though same-week availability may be limited.
It is recommended to fast for at least 8 hours before your draw.
Why it matters: evaluating sex hormones, pituitary signaling, thyroid, and ovarian reserve together offers a nuanced view of how the hormonal system is functioning and how it may change over time.
Who it's for: especially useful for women actively trying to conceive, planning future fertility, or navigating irregular cycles, unexplained infertility, or possible perimenopause.
Cycle timing matters for this panel: mid-luteal (days 19–23) for fertility-focused testing, or early follicular (days 1–5) for hormonal transition assessment.
It is recommended to fast for at least 8 hours before your draw.
Medications sourced from 503A and 503B U.S.-licensed pharmacies.
Lab testing conducted through CLIA-certified laboratories.
Care delivered by board-certified clinicians.
Available in all 50 states and Washington, D.C.